Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
GLOBE, GUARD Demos’ Approach To Licensed Drugs Alarms Small, Mid-Size Firms
Feb 26 2026
•
By
Cathy Kelly
The CMS policy could discourage ex-US licensing arrangements.
(Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Pricing Debate
More from Market Access